Delivra Health Stock Price, News & Analysis

Delivra Health Brands (OTCQB: DHBUF) reported fiscal 2025 results for the 12 months ended June 30, 2025, showing net revenue of $13,370k, up 8% year-over-year from $12,378k. Gross profit rose to $6,778k with a 51% gross margin (vs. 52% in 2024). Adjusted EBITDA was $643k, down from $871k in fiscal 2024, reflecting higher marketing and e-commerce costs.

Brand performance: Dream Water USA & Canada and LivRelief Canada delivered double-digit revenue growth in e-commerce and retail channels, partially offset by lower licensed LivRelief Infused revenues. Fiscal 2025 showed a net loss from continuing operations of $1,190k and operating cash use of $754k.

Delivra Health (OTCQB: DHBUF; TSXV: DHB) will report annual financial results for the year ending June 30, 2025 on Monday, October 6, 2025. The company will host a conference call on Monday, October 6, 2024 at 11:00 a.m. EST / 8:00 a.m. PST featuring CEO Gord Davey and CFO Jack Tasse, followed by a Q&A. Participants may dial 1-833-752-2525 (Canada/USA toll free) or +1-647-846-2674 (international). A replay will be posted on the company's investor page by end of business on October 6, 2025.

Delivra Health Brands (OTCQB: DHBUF) has announced the expansion of its Dream Water brand into the Gulf Cooperation Council (GCC) market with the launch of 6-Count Sleep Gummies. The new product will be available in airports, major pharmacies, and e-commerce channels by September 2025, focusing on Saudi Arabia and other GCC countries.

The company, through its distribution partners in Saudi Arabia, aims to capitalize on the high-growth market for wellness and sleep-support products in the Middle East. Additionally, Delivra Health has granted 100,000 incentive stock options to certain directors, officers, and employees, exercisable at $0.30 per share with a three-year term.

Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has expanded its US presence through a new partnership with QVC, a major televised and online shopping network. The partnership enables Dream Water's Snoozeberry Sleep Shots to reach millions of potential customers through QVC's direct-to-consumer platform. The initial product launch features a 16-pack of Dream Water Snoozeberry Sleep Shots, which first aired on May 31, 2025, and will continue to be available on QVC's website. CEO Gord Davey emphasized that this partnership aligns with the company's strategy to expand distribution channels and leverage QVC's engaging hosts and storytelling approach to build brand loyalty and drive impulse purchases.

Delivra Health Brands (DHBUF) reported its Q3 2025 financial results, showing positive growth and strategic expansion. The company achieved a 3% year-over-year revenue increase to $9,012,000 for the nine months ended March 31, 2025, with positive adjusted EBITDA of $124,000 in Q3. Dream Water brand expanded in Canada with new product launches including Sleep Shot extensions and Sleep Gummies. LivRelief's "Quiets Chronic Pain" campaign drove a 21% increase in units sold to 95,000 units. However, gross profit margin declined to 49% from 52% due to higher costs and product mix changes. The company's strategic marketing investments led to a 15% increase in expenses to $4,585,000, impacting the nine-month adjusted EBITDA which decreased to $(51,000) from $845,000 in the previous year.

Delivra Health Brands Inc. (DHBUF) has announced the expansion of its Dream Water® brand into Middle Eastern markets through the launch of its new 60-Count Sleep Gummies. The product will be distributed through the company's Kuwait-based distributor and is expected to be available in local markets by July 2025.

This strategic expansion builds upon Dream Water's existing success with sleep gummies in Canadian and U.S. markets, complementing their current liquid shot offerings in the Middle East. The move represents a calculated effort to grow the brand's presence through partnerships with local distributors who possess regional market expertise.

Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced the launch of Dream Water® 6-Count Sleep Gummies in the Canadian market. This new product follows the successful introduction of their 60-count Dream Water® Gummies in February 2024.

The 6-Count Sleep Gummies will be available to distributors, retailers, and e-commerce channels in March 2025. According to CEO Gord Davey, this strategic launch aims to capture growth opportunities in the travel and convenience retail channels while strengthening the company's position in sleep solutions.

The product will be distributed nationwide through Delivra Health's established retail and e-commerce partners, building on the momentum of Dream Water Sleep Gummies in both Canadian and US markets.

Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) reported its Q2 2025 financial results, showcasing a 34% net revenue growth to $2,754, up $704 from the same quarter last year. The growth was primarily driven by higher sales of Dream Water® in the U.S. and Canada.

Key financial metrics include:

• Gross profit of $1,294 with a 47% margin (down from 54% last year)
• Increased SG&A expenses of $1,544, up 22% year-over-year
• Adjusted EBITDA of $(194) compared to $(84) in the same period last year

The company increased marketing investments and consumer promotional programs across all channels. Six-month results showed total net revenue of $5,917, a 3% increase, while gross profit decreased to $2,891 with a 49% margin. Management remains confident in achieving their commercial and financial objectives for the fiscal year.

Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced it will release its financial results for Q2 fiscal 2025, covering the three and six months ended December 31, 2024. The company will host a conference call on Thursday, February 27, 2025, at 11:00 a.m. EST to discuss these results.

The conference call will feature a Q&A session led by President and CEO Gord Davey and CFO Jack Tasse. Interested parties can join via toll-free number 1-833-752-2525 (Canada/USA) or +1-647-846-2674 (International). Participants are advised to dial in 10 minutes before the scheduled start time. A replay will be available on the company's investor page following the call.